Clinical Trial Update: Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation [Phase 1]

View source ↗

Summary

Phase 1 trial investigating donor-derived alloantigen-reactive regulatory T cells (darTregs) in liver transplantation; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Liver Transplantation | Phase 1 | Status: TERMINATED | Results posted: 2020-07-20